Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA has appointed Professor Simon Nitter Dankel as Principal Investigator for its upcoming clinical trial of a new CGM implant. This strategic move, in collaboration with the University of Bergen’s Research Unit for Health Surveys, aims to ensure high-quality data collection and regulatory standards, marking a significant step toward the commercial launch of Lifecare’s innovative technology for diabetes management.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing next-generation Continuous Glucose Monitoring (CGM) systems. The company utilizes osmotic pressure as a sensing principle and aims to monitor various body analytes in humans and pets.
Average Trading Volume: 33,627
Current Market Cap: NOK133.2M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.